Renova Therapeutics
Peter Gengo, currently serving as the Vice President at Renova Therapeutics, has a wealth of experience in the pharmaceutical industry. With previous roles as a Principal Scientist/Director at Merck, Senior Director/Research Fellow at Johnson and Johnson, and Senior Director of Pharmacology at Ardent Pharmaceuticals, their expertise is well-established. Peter's career also includes positions at GlaxoWellcome, Burroughs Wellcome Co, and Eli Lilly and Company. Peter holds a Doctor of Philosophy degree in Biochemical Pharmacology from the University at Buffalo Pharmacy and Pharmaceutical Sciences.
This person is not in any teams
Renova Therapeutics
Renova Therapeutics is an industry leader in the emerging field of gene therapy, pursuing the development of treatments for congestive heart failure and other chronic diseases.We are committed to the highest standards in all we do and focus on treatments that can have an enormous impact on a global scale